Cargando…
The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482870/ https://www.ncbi.nlm.nih.gov/pubmed/36165862 http://dx.doi.org/10.1016/j.micpath.2022.105792 |
_version_ | 1784791548781658112 |
---|---|
author | Mosadegh, Mehrdad Khalkhali, Aref Erfani, Yousef Nezamdoost, Manije |
author_facet | Mosadegh, Mehrdad Khalkhali, Aref Erfani, Yousef Nezamdoost, Manije |
author_sort | Mosadegh, Mehrdad |
collection | PubMed |
description | BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study was a randomized, comparative, parallel two-arm and single-blind clinical trial study performed in Tehran, Iran. In total, 70 patients with COVID-19 were included in the present study and assigned to two groups including 1) intervention group (n = 35) and 2) control group (n = 35). All patients included in the intervention group received 4.5 gr daily rate of NBS superfood, three times the daily rate of 1.5 gr for 14 days. In contrast, patients included in the control group received a placebo three times a day for 14 days. The measurement of laboratory parameters including CRP, ESR, D-Dimer, LDH, CPK, SGOT, SGPT, ALP, FBG, WBC count, PLT, and lymphocyte count was performed using standard kits and methods. Moreover, all serum samples were tested to determine the levels of IL-6 and TNF-ɑ using specific commercially available ELISA kits according to the instructions of the manufacturer. RESULTS: A significant decrease in the mean serum level of several variables including CRP (p < 0.001), ESR (p < 0.001), D- Dimer (p = 0.001), LDH (p < 0.001), SGOT (p = 0.002), SGPT (p = 0.019), ALP (p < 0.001), WBC count (p < 0.001), body temperature (p = 0.013), IL-6 (p < 0.001), and TNF-α (p < 0.001) was seen 14 days after intervention from baseline in the intervention group than control group. In contrast, in the intervention group, the significant increase from baseline of lymphocyte percentage (p < 0.001) and oxygen saturation (p < 0.001) was seen 14 days after receiving NBS superfood than the control group. CONCLUSION: Results showed that the use of NBS superfood had various beneficial effects on COVID-19 disease severity. These results suggest that NBS superfood can be used as an effective natural supplement in the treatment process of COVID-19 disease. |
format | Online Article Text |
id | pubmed-9482870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94828702022-09-19 The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial Mosadegh, Mehrdad Khalkhali, Aref Erfani, Yousef Nezamdoost, Manije Microb Pathog Article BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study was a randomized, comparative, parallel two-arm and single-blind clinical trial study performed in Tehran, Iran. In total, 70 patients with COVID-19 were included in the present study and assigned to two groups including 1) intervention group (n = 35) and 2) control group (n = 35). All patients included in the intervention group received 4.5 gr daily rate of NBS superfood, three times the daily rate of 1.5 gr for 14 days. In contrast, patients included in the control group received a placebo three times a day for 14 days. The measurement of laboratory parameters including CRP, ESR, D-Dimer, LDH, CPK, SGOT, SGPT, ALP, FBG, WBC count, PLT, and lymphocyte count was performed using standard kits and methods. Moreover, all serum samples were tested to determine the levels of IL-6 and TNF-ɑ using specific commercially available ELISA kits according to the instructions of the manufacturer. RESULTS: A significant decrease in the mean serum level of several variables including CRP (p < 0.001), ESR (p < 0.001), D- Dimer (p = 0.001), LDH (p < 0.001), SGOT (p = 0.002), SGPT (p = 0.019), ALP (p < 0.001), WBC count (p < 0.001), body temperature (p = 0.013), IL-6 (p < 0.001), and TNF-α (p < 0.001) was seen 14 days after intervention from baseline in the intervention group than control group. In contrast, in the intervention group, the significant increase from baseline of lymphocyte percentage (p < 0.001) and oxygen saturation (p < 0.001) was seen 14 days after receiving NBS superfood than the control group. CONCLUSION: Results showed that the use of NBS superfood had various beneficial effects on COVID-19 disease severity. These results suggest that NBS superfood can be used as an effective natural supplement in the treatment process of COVID-19 disease. Elsevier Ltd. 2022-11 2022-09-19 /pmc/articles/PMC9482870/ /pubmed/36165862 http://dx.doi.org/10.1016/j.micpath.2022.105792 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mosadegh, Mehrdad Khalkhali, Aref Erfani, Yousef Nezamdoost, Manije The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title_full | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title_fullStr | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title_full_unstemmed | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title_short | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
title_sort | effect of nutrition bio-shield superfood (nbs) on disease severity and laboratory biomarkers in patients with covid-19: a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482870/ https://www.ncbi.nlm.nih.gov/pubmed/36165862 http://dx.doi.org/10.1016/j.micpath.2022.105792 |
work_keys_str_mv | AT mosadeghmehrdad theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT khalkhaliaref theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT erfaniyousef theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT nezamdoostmanije theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT mosadeghmehrdad effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT khalkhaliaref effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT erfaniyousef effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial AT nezamdoostmanije effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial |